Effect of colchicine on the outcomes of patients with COVID-19: a systematic review and meta-analysis of randomised controlled trialsCOVID-19 환자의 결과에 대한 콜히친의 영향: 무작위 대조 시험의 체계적인 검토 및 메타 분석Meta-Analysis Published on 2022-12-012022-09-11 Journal: Annals of Medicine [Category] 임상, [키워드] 95% CI addition adverse event adverse events Clinical efficacy clinical outcomes ClinicalTrials Cochrane Library Colchicine control group COVID-19 database diarrhoea Effect higher risk hospital Hospital stay improve clinical outcome mean difference mechanical ventilation Meta-analysis Mortality no significant difference non-invasive ventilation non-invasive ventilation. not reduce Odds ratio outcome OVID Patient patients with COVID-19 Placebo placebos randomised controlled trial RCT RCTs receiving risk SARS-CoV-2 searched significant difference significantly higher standard treatment study group Support systematic review the study group Treatment Web of Science [DOI] 10.1080/07853890.2022.2096919 PMC 바로가기 [Article Type] Meta-Analysis
The safety of esophageal cancer surgery during COVID-19Article Published on 2022-10-142022-11-16 Journal: Medicine [Category] meta-analysis, [키워드] 95% confidence interval anastomotic Blood Cancer Chinese Cochrane Library complications conducted coronavirus disease COVID-19 COVID-19 pandemic database determine evaluate Evidence Fang heterogeneity Hospital stay ICU identify Infrastructure intensive care journal mean difference Meta-analysis Mortality outcome outcomes pandemic Patient postoperative Primary outcome random effect model readmission Registered researchers risk risk ratio secondary outcome surgical systematic review Trial was performed Web of Science were used [DOI] 10.1097/MD.0000000000030929 PMC 바로가기
Effectiveness of prone position in acute respiratory distress syndrome and moderating factors of obesity class and treatment durations for COVID-19 patients: A meta-analysisResearch article Published on 2022-10-012022-10-05 Journal: Intensive & critical care nursing [Category] COVID19(2023년), SARS, 치료법, [키워드] 95% CI 95%CI acute respiratory distress acute respiratory distress syndrome Analysis article body mass index calculated CINAHL conducted coronavirus 2 COVID-19 COVID-19 patient effect size Effectiveness eligible experimental design Factor Final Invasive mechanical ventilation mean difference Meta-analysis methodology NCBI non-invasive ventilation obesity objective oxygen saturation PaO2 paO2/fiO2 Patient patients patients with COVID-19 prone Prone position prone positioning ProQuest Respiratory failure Result SARS-CoV-2 secondary outcome significantly SpO2 statistically significant syndrome Treatment Web of Science [DOI] 10.1016/j.iccn.2022.103257 [Article Type] Research article
Psychiatric treatment conducted via telemedicine versus in-person consultations in mood, anxiety and personality disorders: a protocol for a systematic review and meta-analysisArticle Published on 2022-09-282022-11-16 Journal: BMJ Open [Category] meta-analysis, [키워드] 95% CI adult psychiatry Anxiety APA approval assessment Bia calculate calculated Chi-square CINAHL comparable conducted COVID-19 COVID-19 pandemic cumulative data set development disorders dropout rate Effect Ethics Evidence heterogeneity include information technology Intervention Major mean difference Meta-analysis methodological outcomes participant Patient satisfaction platform Potential Primary outcome PROSPERO protocol Psychiatric Psychiatric disorders psychiatry PsycINFO randomised controlled trial Repository required risk risk of bia secondary outcome sensitivity analysis systematic review Telemedicine telemedicine. test for heterogeneity Treatment Web of Science widespread [DOI] 10.1136/bmjopen-2021-060690 PMC 바로가기
Vitamin D Supplementation Does Not Influence SARS-CoV-2 Vaccine Efficacy or Immunogenicity: Sub-Studies Nested within the CORONAVIT Randomised Controlled TrialArticle Published on 2022-09-162022-11-15 Journal: Nutrients [Category] SARS, 진단, [키워드] 25-hydroxyvitamin D 95% CI Acute respiratory infection adjusted hazard ratio antibody baseline blood sample BNT162b2 BNT162b2 Pfizer boost Breakthrough SARS-CoV-2 infection cellular response ChAdOx1 nCoV-19 ChAdOx1 nCoV-19 Oxford–AstraZeneca circulating collected Concentration concentrations Controlled deficiency determine dose dried blood spot Effect Efficacy elevated Follow-up IFN-γ IgA IgG IgM influence interferon interferon gamma investigated mean difference neutralising antibody neutralising antibody titre of BNT162b2 offer participant Pfizer Protective randomised controlled randomised controlled trial reported response risk SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 vaccination SARS-CoV-2 vaccine significantly supernatant titre titres vaccination venous Vitamin Vitamin D Vitamin D status vitamin D supplement Vitamin D supplementation vitamin D. Whole blood [DOI] 10.3390/nu14183821 PMC 바로가기
Harmonization of SARS-CoV-2 reverse transcription quantitative PCR tests to the first WHO international standard for SARS-CoV-2 RNASARS-CoV-2 RNA에 대한 최초의 WHO 국제 표준에 SARS-CoV-2 역전사 정량 PCR 테스트의 조화Article Published on 2022-09-012022-09-11 Journal: Journal of Clinical Virology [Category] COVID19(2023년), SARS, 유전자 메커니즘, 치료법, [키워드] 95% CI 95% confidence interval Analysis assays association calibration Cepheid clinical samples comparable confidence Ct value Ct values cycle cycle threshold Emergency use evaluate Generalizability generate greater harmonization IMPROVE International international standard interquartile range interval IQR log mean difference median nucleocapsid platform positive quantitation Quantitative quantitative PCR Range Regression reverse transcription RT-qPCR RT-qPCRs SARS-CoV-2 SARS-CoV-2 RNA Standard target targets the mean the WHO threshold upper respiratory viral burden was tested WHO [DOI] 10.1016/j.jcv.2022.105242 PMC 바로가기 [Article Type] Article
The effect of influenza vaccine in reducing the severity of clinical outcomes in patients with COVID-19: a systematic review and meta-analysis Research Published on 2022-08-222022-10-05 Journal: Scientific Reports [Category] 치료법, [키워드] 95% CI 95% confidence interval Admission Analysis CIs Clinical outcome clinical outcomes COVID-19 COVID-19 pandemic COVID-19 patient database Evidence favor FIVE fixed group heterogeneity Hospital admission indicated Infection Influenza intensive care limitations mean difference mechanical ventilation Meta-analysis mortality rate no significant difference observational study outcomes Patient random effect recent reduce reducing reported Research risk searched severity severity of COVID-19 significantly lower statistically significant difference systematic review vaccination Vaccine [DOI] 10.1038/s41598-022-18618-6 [Article Type] Research
The Associations of Iron Related Biomarkers with Risk, Clinical Severity and Mortality in SARS-CoV-2 Patients: A Meta-AnalysisSARS-CoV-2 환자의 위험, 임상 중증도 및 사망률과 철분 관련 바이오마커의 연관성: 메타 분석Review Published on 2022-08-192022-09-11 Journal: Nutrients [Category] SARS, 바이오마커, 치료기술, [키워드] 95% confidence interval acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 addition article Biomarker calculation caused clinical coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 progression deaths disease Diseases eligible evaluate Evidence ferritin ferritin level ferritin levels hemoglobin heterogeneity indicate Infection iron Iron metabolism iron. magnitude mean difference Meta-analysis metabolism Mortality non-survivor Non-survivors Occurrence opposite Patient peer-reviewed Previous studies previous study progression random effect respiratory risk SARS-CoV-2 searched serum severe acute respiratory syndrome Coronavirus severity significantly lower SMD Survivors the disease TIBC was used Web of Science with COVID-19 [DOI] 10.3390/nu14163406 PMC 바로가기 [Article Type] Review
Seven Months after Mild COVID-19: A Single-Centre Controlled Follow-Up Study in the District of Constance (FSC19-KN)Clinical Trial Published on 2022-08-122022-10-04 Journal: International journal of clinical practice [Category] SARS, 임상, [키워드] 6MWT 95% CI acute respiratory syndrome Admission age both group calculation Cardiopulmonary cardiovascular risk clinical Cohort Controlled coronavirus COVID-19 COVID-19 case defined diagnose Diagnosis District Effect Endpoint European exposure Follow-up form Frequency functional Functional status Hospitalization Infection initial inpatient admission mean difference measure mechanism Mild Month no significant difference not differ observation occurred outcome participant PCR physical polymerase chain positive positive patient profile provided Quality Quality of life recruitment reduced Registered Registration reported SARS-CoV-2 SARS-CoV-2 antibody SARS-COV-2 infection secondary setting Seven significantly significantly lower significantly more study population subject subjects Test the primary endpoint the SARS-CoV-2 Trial [DOI] 10.1155/2022/8373697 PMC 바로가기 [Article Type] Clinical Trial
Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with COVID-19: an open-label randomized controlled trialRandomized Controlled Trial Published on 2022-08-092022-10-04 Journal: Respiratory Research [Category] SARS, 임상, [키워드] 95% CI 95% confidence interval age Antibiotic prophylaxis assigned baseline Clinical outcome complement Complement 5 complement system Concentration control group COVID-19 COVID-19 patient Day Efficacy and safety Hypoxemia Inflammation inhibitor long-term follow up mean difference men Mortality MOST multicenter Odds ratio Open-label Oxygenation PaO Patient patients hospitalized primary analysis Primary outcome Randomized Randomized controlled trial randomized studies randomized trial Randomly receive Research Respiratory function serum Standard of care statistical significance systemic systemic inflammation systemic inflammation. the median Trial while zilucoplan [DOI] 10.1186/s12931-022-02126-2 PMC 바로가기 [Article Type] Randomized Controlled Trial